04:39 PM EDT, 03/12/2025 (MT Newswires) -- Anika Therapeutics ( ANIK ) reported a Q4 adjusted loss late Wednesday of $0.03 per share, swinging from adjusted income of $0.07 a year earlier.

Two analysts polled by FactSet expected a loss of $0.23.

Revenue for the quarter ended Dec. 31 was $30.6 million, up from $30.2 million a year earlier. Two analysts surveyed by FactSet expected $29 million.

The company's shares were down 6% in recent after-hours activity.